Page last updated: 2024-08-25

nodakenin and Shock, Septic

nodakenin has been researched along with Shock, Septic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, W; Lee, KT; Rim, HK; Sung, SH	1

Other Studies

1 other study(ies) available for nodakenin and Shock, Septic

Article	Year
Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock. The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Coumarins; Cyclooxygenase 2; Dinoprostone; Down-Regulation; Drug Interactions; Glucosides; I-kappa B Kinase; I-kappa B Proteins; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Promoter Regions, Genetic; Shock, Septic; Signal Transduction; TNF Receptor-Associated Factor 6; Transcription, Genetic; Tumor Necrosis Factor-alpha; Ubiquitination	2012

Article

Year

Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.

The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:3

Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Coumarins; Cyclooxygenase 2; Dinoprostone; Down-Regulation; Drug Interactions; Glucosides; I-kappa B Kinase; I-kappa B Proteins; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Promoter Regions, Genetic; Shock, Septic; Signal Transduction; TNF Receptor-Associated Factor 6; Transcription, Genetic; Tumor Necrosis Factor-alpha; Ubiquitination

2012